599 research outputs found

    HPI MEDICAID DRUG SPENDING AFTER THE MEDICARE MODERNIZATION ACT: WHAT WILL BE LEFT?

    Get PDF

    PNL11 HEALTH CARE COSTS FOR FLORIDA MEDICAID RECIPIENTS WITH MULTIPLE SCLEROSIS

    Get PDF

    PCP3: THE ECONOMIC COST OF ACETAMINOPHENRELATED LIVER TOXICITY TO THE CALIFORNIA MEDICAID PROGRAM

    Get PDF

    Anti-NMDA receptor encephalitis with neurologic sequelae refractory to conservative therapy with complete response to adjuvant therapy

    Get PDF
    © 2020 The Authors Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis has been described in increasing frequency in association with benign, mature ovarian teratoma. Affected patients typically present with paraneoplastic limbic encephalitis with flu-like symptoms followed by altered mental status, acute psychiatric symptoms, seizures and amnesia. These symptoms can rapidly progressive if not treated aggressively with surgical resection. Profound neurological symptoms may require immunotherapy. Case: We present a case of anti-NMDA receptor encephalitis associated with a malignant immature teratoma in which symptoms were refractory to surgical management and initial immunotherapy. A complete neurologic response was only seen after initiating adjuvant chemotherapy. Conclusion: Anti-NMDA receptor encephalitis has rarely been described with immature ovarian teratomas. In these cases, a complete response may not be observed until systemic chemotherapy is started

    PCO4 EPISODES OF RESPIRATORY CARE FOR MANAGED CARE PATIENTS WITH COPD: ASSESSING THE ECONOMIC BURDEN

    Get PDF

    RI2 THE EXCESS COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FROM A MANAGED-CARE PERSPECTIVE

    Get PDF
    • …
    corecore